共 8 条
[1]
A more meaningful scoring system for determining the severity of coronary heart disease. Gwnsins GG. The American Journal of Cardiology . 1983
[2]
A protective study of plasma homocysteine and risk of myocardial infarction in US physicians. Stampfer MJ,Malinow MR,Willett WC,et al. The Journal of The American Medical Association . 1992
[3]
Hyperhomocysteinemia and low pyridoxal phosphate:Common and independent reversible risk factors for coronary artery disease. Robinson K,Mayer EL,Miller DP,et al. Circulation . 1995
[4]
Abnormally high thromboxane biorynthesis in homozygous homocystinuria:Evidence for platelet involvement and probucol sensitive mechanism. Di MG,Davi G,Margaglione M,et al. The Journal of Clinical Investigation . 1993
[5]
Homocyteine and risk of premature coronary heart disease: Evidence for a common gene mutation. Gallagher PM,Meleady R,Shields DC,et al. Circulation . 1996
[6]
On the limitation of therapeutic intervention trials in ischemic heart disease: A clinician′s viewpoint. Seizer A. The American Journal of Cardiology . 1982
[7]
Hyperhomocysteinemia-an emerging and important risk factor for thromboembolic and cardiovascular disease. Susan C,Louis M,Vivlan F. Clinical Chemistry . 1996
[8]
Plasma homocysteine as an risk factor for vascular disease. Graham LM,Leslie ED,Helga MR,et al. The Journal of The American Medical Association . 1997